Literature DB >> 22433915

Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans.

D J Birmingham1, L A Hebert, H Song, W T Noonan, B H Rovin, H N Nagaraja, C Y Yu.   

Abstract

Cross-sectional studies have shown that low vitamin D (25-hydroxyvitamin D (25(OH)D)) is associated with increased systemic lupus erythematosus (SLE) activity. This study is the first to assess the temporal relationship between 25(OH)D levels and onset of SLE flare. This assessment was made possible because of the specimen bank and database of the Ohio SLE Study (OSS), a longitudinal study of frequently relapsing SLE that involved regular bimonthly patient follow-up. We identified for this study 82 flares from 46 patients that were separated by at least 8 months from previous flares. Serum 25(OH)D levels were measured at 4 and 2 months before flare, and at the time of flare (a flare interval). We found that for flares occurring during low daylight months (LDM, Oct-Mar), 25(OH)D levels were decreased at the time of flare, but only in non-African American (non-AA) patients (32% decrease at flare, compared to 4 months prior, p < 0.001). To control for seasonal effects, we also measured 25(OH)D levels in the LDM "no-flare" intervals, which were intervals that matched to the same calendar months of the patients' LDM flare intervals, but that didn't end in flare (n = 24). For these matches, a significant decrease occurred in 25(OH)D levels during the flare intervals (18.1% decrease, p < 0.001), but not during the matching no-flare intervals (6.2% decrease, p = 0.411). For flares occurring during high daylight months (HDM), 25(OH)D levels changed only in non-AA patients, increasing slightly (5.6%, p = 0.010). Analysis of flare rates for the entire OSS cohort (n = 201 flares) revealed a tendency for higher flare rates during LDM compared to HDM, but again only in non-AA patients (p = 0.060). Flare rates were lower during HDM for non-AA patients compared to AA patients (p = 0.028). In conclusion, in non-AA SLE patients, unusually large declines in 25(OH)D during LDM may be mechanistically related to SLE flare, whereas relatively high 25(OH)D levels during HDM may protect against flare.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22433915      PMCID: PMC3839052          DOI: 10.1177/0961203312439640

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  53 in total

1.  Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3.

Authors:  Xiahoui Rausch-Fan; Fritz Leutmezer; Martin Willheim; Andreas Spittler; Barbara Bohle; Christof Ebner; Erika Jensen-Jarolim; George Boltz-Nitulescu
Journal:  Int Arch Allergy Immunol       Date:  2002-05       Impact factor: 2.749

2.  Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo.

Authors:  M D Griffin; W Lutz; V A Phan; L A Bachman; D J McKean; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 3.  Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis.

Authors:  Chi Chiu Mok; Daniel J Birmingham; Hoi Wah Leung; Lee A Hebert; Huijuan Song; Brad H Rovin
Journal:  Rheumatology (Oxford)       Date:  2011-06-29       Impact factor: 7.580

4.  A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; S P Lan; R D Rohde; J M Lachin
Journal:  N Engl J Med       Date:  1992-05-21       Impact factor: 91.245

5.  LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study.

Authors:  Donato Alarcón-Segovia; James A Tumlin; Richard A Furie; James D McKay; Mario H Cardiel; Vibeke Strand; Robert G Bagin; Matthew D Linnik; Bonnie Hepburn
Journal:  Arthritis Rheum       Date:  2003-02

6.  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.

Authors:  E M Hay; P A Bacon; C Gordon; D A Isenberg; P Maddison; M L Snaith; D P Symmons; N Viner; A Zoma
Journal:  Q J Med       Date:  1993-07

7.  Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells.

Authors:  Jana Fritsche; Krishna Mondal; Achim Ehrnsperger; Reinhard Andreesen; Marina Kreutz
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

8.  Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis.

Authors:  J S Adams; O P Sharma; M A Gacad; F R Singer
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

Review 9.  Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.

Authors:  Yan Chun Li; Guilin Qiao; Milan Uskokovic; Wei Xiang; Wei Zheng; Juan Kong
Journal:  J Steroid Biochem Mol Biol       Date:  2004-05       Impact factor: 4.292

10.  Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin.

Authors:  A R Webb; L Kline; M F Holick
Journal:  J Clin Endocrinol Metab       Date:  1988-08       Impact factor: 5.958

View more
  17 in total

1.  Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis.

Authors:  Dawn J Caster; Erik A Korte; Michael L Merchant; Jon B Klein; Daniel W Wilkey; Brad H Rovin; Dan J Birmingham; John B Harley; Beth L Cobb; Bahram Namjou; Kenneth R McLeish; David W Powell
Journal:  Proteomics Clin Appl       Date:  2015-06-12       Impact factor: 3.494

Review 2.  Topics on vitamin D in systemic lupus erythematosus: analysis of evidence and critical literature review.

Authors:  António Marinho; Mariana Taveira; Carlos Vasconcelos
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 3.  The role of vitamin D supplementation in patients with rheumatic diseases.

Authors:  Bo Abrahamsen; Nicholas C Harvey
Journal:  Nat Rev Rheumatol       Date:  2013-05-14       Impact factor: 20.543

4.  Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.

Authors:  Daniel J Birmingham; Joshua E Bitter; Ezinne G Ndukwe; Sarah Dials; Terese R Gullo; Sara Conroy; Haikady N Nagaraja; Brad H Rovin; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 8.237

5.  Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.

Authors:  Kendra A Young; Melissa E Munroe; Joel M Guthridge; Diane L Kamen; Timothy B Niewold; Gary S Gilkeson; Michael H Weisman; Mariko L Ishimori; Jennifer Kelly; Patrick M Gaffney; Kathy H Sivils; Rufei Lu; Daniel J Wallace; David R Karp; John B Harley; Judith A James; Jill M Norris
Journal:  Ann Rheum Dis       Date:  2016-06-09       Impact factor: 19.103

6.  Serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus: a longitudinal cohort analysis.

Authors:  Chi Chiu Mok; Eric T Bro; Ling Yin Ho; Ravinder J Singh; Paul J Jannetto
Journal:  Clin Rheumatol       Date:  2018-07-16       Impact factor: 2.980

Review 7.  Vitamin D treatment for connective tissue diseases: hope beyond the hype?

Authors:  John A Reynolds; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2016-05-13       Impact factor: 7.580

8.  Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up.

Authors:  Yoland Schoindre; Moez Jallouli; Marie-Laure Tanguy; Pascale Ghillani; Lionel Galicier; Olivier Aumaître; Camille Francès; Véronique Le Guern; Frédéric Lioté; Amar Smail; Nicolas Limal; Laurent Perard; Hélène Desmurs-Clavel; Du Le Thi Huong; Bouchra Asli; Jean-Emmanuel Kahn; Laurent Sailler; Félix Ackermann; Thomas Papo; Karim Sacré; Olivier Fain; Jérôme Stirnemann; Patrice Cacoub; Gaëlle Leroux; Judith Cohen-Bittan; Jean-Sébastien Hulot; Philippe Lechat; Lucile Musset; Jean-Charles Piette; Zahir Amoura; Jean-Claude Souberbielle; Nathalie Costedoat-Chalumeau
Journal:  Lupus Sci Med       Date:  2014-06-07

9.  Vitamin D Levels Are Associated with Expression of SLE, but Not Flare Frequency.

Authors:  Marline L Squance; Glenn E M Reeves; Huy A Tran
Journal:  Int J Rheumatol       Date:  2014-11-24

10.  Greater seasonal cycling of 25-hydroxyvitamin D is associated with increased parathyroid hormone and bone resorption.

Authors:  A L Darling; K H Hart; M A Gibbs; F Gossiel; T Kantermann; K Horton; S Johnsen; J L Berry; D J Skene; R Eastell; R Vieth; S A Lanham-New
Journal:  Osteoporos Int       Date:  2013-08-28       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.